SUGAR TRANSPORTER OLIGOMERIC STRUCTURE AND FUNCTION
糖转运蛋白寡聚结构和功能
基本信息
- 批准号:2905478
- 负责人:
- 金额:$ 14.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-05-01 至 2000-05-31
- 项目状态:已结题
- 来源:
- 关键词:CHO cells allosteric site binding proteins blood brain barrier chemical association chimeric proteins complementary DNA computer assisted sequence analysis conformation dimer disulfide bond erythrocytes glucose transport high performance liquid chromatography human genetic material tag immunoprecipitation intermolecular interaction ligands membrane transport proteins protein purification protein structure function transfection western blottings
项目摘要
Cellular nutrient and electrolyte transport is a fundamental but
incompletely characterized biological process mediated by two broad
classes of transport mechanism - channels and carriers. All mammalian
cells transport sugars by a carrier-mediated transport mechanism called
glucose uniport or glucose transport. This crucial cellular process
provides sugars for ATP synthesis, for maintenance of reducing potential
and for the biosynthesis of sugar-containing macromolecules such as
glycoproteins, glycolipids and nucleic acids. Sugar transport in muscle,
liver and the blood brain barrier are also critically important to
organismal energy homeostasis. Impaired transport by these tissues is
manifest in diseases that include diabetes, glycogen storage diseases and
blood brain barrier disorders.
Glucose transport involves catalytic steps common to all carrier-mediated
transport mechanisms. Because it is abundantly expressed, the red blood
cell and blood brain barrier glucose transport system is amenable to
biophysical, biochemical and molecular analysis. This system has thus
become a prototype not only for studies of the biologically important
sugar transport process but also for understanding the wider family of
carrier mechanisms. Despite extensive analysis, the structural basis of
protein mediated sugar transport process is unknown. Our long term goal
is to understand the molecular mechanism of sugar transport. We propose
the following aims in our continuing efforts towards this goal:
1) We have demonstrated that the erythrocyte glucose transporter is an
allosteric complex of four identical subunits - the GLUT1 protein. This
structure is present in all GLUT1-expressing mammalian cells examined to
date. Tetrameric GLUT1 is stabilized by non-covalent interactions between
subunits which require a subunit-fold promoted by an intra-subunit
disulfide bridge. Disulfide disruption causes transporter dissociation
into dimers. Subunits of dimeric and tetrameric GLUT1 appear to interact
through N-terminal domains (GLUT1 residues 1-199). Precisely what
subsequences mediate these interactions and how these interactions lead
to oligomerization are unknown. We outline a co-immunoprecipitation
strategy using chimeric transporters to broadly map these domains and to
begin to understand their role in GLUT1 oligomerization.
2) Tetrameric GLUT1 transports sugars 15-fold more rapidly than does
dimeric GLUT1 and, unlike dimeric GLUT1, is characterized by
heterotropic, cooperative interactions between sugar import and export
sites. Our recent studies show that cooperative ligand binding is not
always required for rapid sugar transport and that other, uncharacterized
subunit interactions promote rapid substrate translocation by tetrameric
GLUT1. We describe sugar transport and ligand binding experiments that
exploit chimeric transporters from Aim 1 to map GLUT1 domains required
for rapid transport function and/or cooperative ligand binding. We
thereby determine whether these domains are separate from or identical
to oligomerization domains.
细胞营养和电解质的运输是一个基本的,
不完全表征的生物过程由两个广泛的
传输机制的分类--信道和载波。所有哺乳动物
细胞通过载体介导的转运机制转运糖,
葡萄糖单端口或葡萄糖转运。这个至关重要的细胞过程
为ATP合成提供糖,以维持还原电位
以及用于含糖大分子的生物合成,
糖蛋白、糖脂和核酸。糖在肌肉中的运输,
肝脏和血脑屏障也至关重要,
机体能量平衡这些组织的运输受损,
在包括糖尿病、糖原累积病和
血脑屏障障碍
葡萄糖转运涉及所有载体介导的
运输机制。因为它被大量表达,红色的血液
细胞和血脑屏障葡萄糖转运系统
生物物理、生物化学和分子分析。因此,该系统
不仅成为研究生物学重要性的原型,
糖的运输过程,也为了解更广泛的家庭
载体机制尽管进行了广泛的分析,
蛋白质介导的糖转运过程是未知的。我们的长期目标
是了解糖运输的分子机制。我们提出
在我们为实现这一目标而不断努力的过程中,我们的目标如下:
1)我们已经证明红细胞葡萄糖转运蛋白是一种
四个相同亚基的变构复合物-GLUT 1蛋白。这
结构存在于所有检测的表达GLUT 1的哺乳动物细胞中,
约会四聚体GLUT 1通过以下物质之间的非共价相互作用而稳定:
需要由亚基内启动的亚基折叠的亚基
二硫桥二硫键破坏导致转运蛋白解离
变成二聚体二聚体和四聚体GLUT 1的亚基似乎相互作用
通过N-末端结构域(GLUT 1残基1-199)。但正是这种
顺应性介导这些相互作用,以及这些相互作用如何导致
低聚化的可能性是未知的。我们概述了免疫共沉淀
使用嵌合转运蛋白的策略来广泛地定位这些结构域,
开始了解它们在GLUT 1寡聚化中的作用。
2)四聚体GLUT 1转运糖的速度比正常情况快15倍
二聚体GLUT 1,与二聚体GLUT 1不同,其特征在于
糖进口和出口之间的异向合作相互作用
网站.我们最近的研究表明,合作配体结合不是
糖的快速运输总是需要的,另一个,
亚基相互作用促进四聚体快速底物转运
GLUT 1。我们描述了糖转运和配体结合实验,
利用来自Aim 1的嵌合转运蛋白绘制所需的GLUT 1结构域
用于快速转运功能和/或协同配体结合。我们
从而确定这些结构域是独立的还是相同的
到寡聚化结构域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTHONY CARRUTHERS其他文献
ANTHONY CARRUTHERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTHONY CARRUTHERS', 18)}}的其他基金
SUGAR TRANSPORTER OLIGOMERIC STRUCTURE AND FUNCTION
糖转运蛋白寡聚结构和功能
- 批准号:
3246405 - 财政年份:1992
- 资助金额:
$ 14.54万 - 项目类别:
SUGAR TRANSPORTER OLIGOMERIC STRUCTURE AND FUNCTION
糖转运蛋白寡聚结构和功能
- 批准号:
3246404 - 财政年份:1992
- 资助金额:
$ 14.54万 - 项目类别:
How glucose transporter structure affects its function
葡萄糖转运蛋白结构如何影响其功能
- 批准号:
8733151 - 财政年份:1992
- 资助金额:
$ 14.54万 - 项目类别:
SUGAR TRANSPORTER OLIGOMERIC STRUCTURE AND FUNCTION
糖转运蛋白寡聚结构和功能
- 批准号:
2144152 - 财政年份:1992
- 资助金额:
$ 14.54万 - 项目类别:
SUGAR TRANSPORTER OLIGOMERIC STRUCTURE AND FUNCTION
糖转运蛋白寡聚结构和功能
- 批准号:
2430197 - 财政年份:1992
- 资助金额:
$ 14.54万 - 项目类别:
相似海外基金
Allosteric site prediction and transmission of functional residues with atomistic graph analysis
通过原子图分析进行功能残基的变构位点预测和传递
- 批准号:
2859072 - 财政年份:2020
- 资助金额:
$ 14.54万 - 项目类别:
Studentship
Creation of novei anticancer lead compounds targeting the allosteric site of c-Met kinase
创建针对 c-Met 激酶变构位点的新型抗癌先导化合物
- 批准号:
16K08327 - 财政年份:2016
- 资助金额:
$ 14.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studying how a general allosteric site regulates protein kinase function
研究一般变构位点如何调节蛋白激酶功能
- 批准号:
8595027 - 财政年份:2013
- 资助金额:
$ 14.54万 - 项目类别:
Studying how a general allosteric site regulates protein kinase function
研究一般变构位点如何调节蛋白激酶功能
- 批准号:
8874171 - 财政年份:2013
- 资助金额:
$ 14.54万 - 项目类别:
Studying how a general allosteric site regulates protein kinase function
研究一般变构位点如何调节蛋白激酶功能
- 批准号:
8704718 - 财政年份:2013
- 资助金额:
$ 14.54万 - 项目类别:
STRUC DETERMINATION OF METAL-SUBSTITUTED & ALLOSTERIC SITE VARIANTS OF H INFLU
金属取代物的结构测定
- 批准号:
7955561 - 财政年份:2009
- 资助金额:
$ 14.54万 - 项目类别:
EXAMINATION OF ALLOSTERIC SITE OF SEROTONIN TRANSPORTER USING TRANSGENIC MICE
使用转基因小鼠检查血清素转运蛋白的变构位点
- 批准号:
7715783 - 财政年份:2008
- 资助金额:
$ 14.54万 - 项目类别:
STRUC DETERMINATION OF METAL-SUBSTITUTED & ALLOSTERIC SITE VARIANTS OF H INFLU
金属取代物的结构测定
- 批准号:
7721325 - 财政年份:2008
- 资助金额:
$ 14.54万 - 项目类别:
ALLOSTERIC SITE STRUCTURES OF CARDIOVASCULAR CHANNELS
心血管通道的变构位点结构
- 批准号:
7215384 - 财政年份:2007
- 资助金额:
$ 14.54万 - 项目类别:
EXAMINATION OF ALLOSTERIC SITE OF SEROTONIN TRANSPORTER USING TRANSGENIC MICE
使用转基因小鼠检查血清素转运蛋白的变构位点
- 批准号:
7562646 - 财政年份:2007
- 资助金额:
$ 14.54万 - 项目类别: